Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Salih Burcin Kavak is active.

Publication


Featured researches published by Salih Burcin Kavak.


Clinical Biochemistry | 2013

Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarum

Sami Gungor; Bilgin Gurates; Suleyman Aydin; Ibrahim Sahin; Salih Burcin Kavak; Selahattin Kumru; Husnu Celik; Aziz Aksoy; Musa Yilmaz; Zekiye Catak; Cihan Citil; Yakup Baykuş; Rulin Deniz; Fethi Karakaya; Nazan Özdemir

OBJECTIVES The goal of this study was to compare levels of acyl and des-acyl ghrelin, obestatin, nesfatin-1 and leptin in healthy gravidas to hyperemesis gravidarum (HG) patients. DESIGN AND METHODS Twenty pregnant women with HG and twenty healthy pregnant women all of similar ages, BMI and all at similar pregnancy development comprised the study cohort. Fasting serum samples were obtained and measured for acyl and des-acyl ghrelin, leptin, obestatin and nesfatin-1. RESULTS Nesfatin-1 concentrations in the HG group were higher compared to the control group whereas; leptin concentrations during pregnancy were lower in the HG group as compared to the control group. The two groups did not differ with regard to acyl and des-acyl ghrelin and obestatin. CONCLUSION This pilot study suggests a possible role of leptin and nesfatin-1, which might be involved in the pathology of the disease.


Drug Design Development and Therapy | 2015

Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study.

Şehmus Pala; Remzi Atilgan; Zehra Sema Ozkan; Salih Burcin Kavak; Nevin Ilhan; Nusret Akpolat; Ekrem Sapmaz

Objective To examine the effects of low-to-high doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome (OHSS) in an experimental setting. Materials and methods A total of 20 female Wistar albino rats, 22 days of age, were randomly divided into four groups. Follicle-stimulating hormone 10 IU was administered subcutaneously in 15 rats on 4 consecutive days, with OHSS induction on day 5 by 30 IU of human chorionic gonadotropin. Group 1 (n=5) comprised 35-day-old control rats, group 2 (n=5) 35-day-old OHSS rats, group 3 (n=5) 27-day-old OHSS rats receiving 1 mg/kg of oral tamoxifen for 7 days, group 4 (n=5) 27-day-old OHSS rats receiving 3 mg/kg of oral tamoxifen for 7 days. All rats were decapitated on day 35. Serum VEGF, endothelin 1, and ovarian follicular reserve were assessed in all rats. Kruskal–Wallis variance analysis and the Mann–Whitney U-test were used for statistical comparisons. A Bonferroni correction was performed to control the inflation of significance, with a significance level set at a P-value of less than 0.025. Results Despite higher serum VEGF, endothelin 1, follicular reserve, and angiogenesis and fibrosis of the corpus luteum in the OHSS group compared to controls, these differences were not significant (P>0.025, Mann–Whitney U-test). There was a significant reduction in the ovarian follicular reserve in tamoxifen groups compared to controls (P<0.025, Mann–Whitney U-test), while angiogenesis of the corpus luteum, number of atretic follicles, fibrosis, and serum VEGF were significantly higher in rats receiving tamoxifen (P<0.025, Mann–Whitney U-test). Also, significantly lower follicular reserve and fibrosis were observed among rats in the low-dose tamoxifen group in comparison with rats in the high-dose tamoxifen group (P<0.025, Mann–Whitney U-test). No groups had a significant change in endothelin 1 levels (P>0.025, Mann–Whitney U-test). Conclusion Tamoxifen 1 g and 3 g resulted in a dose-dependent increase in VEGF and endothelin 1 levels, and ovarian follicle reserves were significantly reduced in our experimental model.


Journal of Perinatal Medicine | 2013

Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa.

Salih Burcin Kavak; Remzi Atilgan; İsmail Demirel; Ebru Celik; Rasit Ilhan; Ekrem Sapmaz

Abstract Aim: To compare the efficiency of endouterine hemostatic square suture and the Bakri balloon tamponade in the treatment of bleeding due to complete placenta previa (CPP). Methods: Thirteen patients with the diagnosis of CPP and intractable bleeding were randomly divided into two groups in a single blind study. Group 1 (n=6) included patients in whom endouterine hemostatic square suture was applied, while group 2 (n=7) included patients in whom Bakri balloon tamponade was applied. The two groups were compared according to the maternal outcomes, the duration of caesarean section, the preoperative and the postoperative hemoglobin and hematocrit (Htc) values, the intraoperative and postoperative blood loss, as well as the newborn characteristics. Results: The duration of operation and the amount of intraoperative bleeding were significantly higher in group 1 (time: 78.3±8.1 vs. 62.8±3.9 min; P<0.05; intraoperative bleeding: 1946±242 vs. 1520±92 mL; P<0.05). The postoperative 24th h Htc values were found to be significantly lower in group 1 than in group 2 (25.6±3.7 vs. 29.5±1.3 g/dL; P<0.05). The postoperative blood loss was higher in group 1 than in group 2. (351±70 vs. 120±56 mL; P<0.05). Conclusion: There are two methods that are effective in preventing bleeding in CPP. However, the Bakri balloon tamponade may be a better alternative due to a shorter operation time and less blood loss.


Case reports in anesthesiology | 2012

Anesthesia and Intensive Care Management in a Pregnant Woman with PRES: A Case Report

İsmail Demirel; Ayşe Belin Özer; Mustafa Kemal Bayar; Salih Burcin Kavak

Posterior reversible encephalopathy syndrome (PRES) is a temporary condition that is diagnosed clinically, neurologically, and radiologically. Its symptoms vary, and nonspecific headaches, confusion, impairment of consciousness, nausea, vomiting, and visual impairment may occur. Acute hypertension often accompanies these symptoms. Patients can also suffer from convulsions, cortical visual impairment, and coma. Diagnosis can be difficult due to focal neurologic signs. Nevertheless, knowing the clinical risk factors can lead to the right diagnosis. It has been reported that this condition may also occur during organ transplantation, immunosuppressive treatment, and autoimmune diseases and chemotherapy, and also patients with eclampsia. In this paper, a 21-year-old, 31-week pregnant woman, who had been diagnosed with PRES and thanks to early diagnosis and treatment had fully recovered and discharged from the intensive care unit, is presented, and the relevant literature is discussed.


Journal of Maternal-fetal & Neonatal Medicine | 2016

Tenascin C levels in patients with mild and severe preeclampsia

Ugur Orak; Ebru Celik; Salih Burcin Kavak; İsmail Demirel; Remzi Atilgan; Suleyman Aydin; Ekrem Sapmaz

Abstract Objective: To determine the serum tenascin-C (TN-C) levels in cases with mild and severe preeclampsia. Methods: Pregnant women were divided into three groups, namely healthy pregnants (Group 1, n = 20), pregnants with mild preeclampsia (Group 2, n = 20) and pregnants with severe preeclampsia (Group 3, n = 20). The groups were formed so as to match each other in terms of gestational week. From each pregnant woman, pre- and post-delivery blood samples were obtained to measure serum TN-C levels. The data were evaluated using the Kruskall–Wallis variance analysis. For the obtained values of p < 0.05, the groups were compared in pairs. A p value of < 0.017 was accepted as significant. Results: In Groups 1, 2 and 3, the prepartum TN-C levels were 5.02 ± 0.4 µg/ml, 12.8 ± 2.9 µg/ml and 33.8 ± 11.7 µg/ml, and in the postpartum TN-C levels were 4.7 ± 0.1 µg/ml, 11.7 ± 1.8 µg/ml and 50.6 ± 33.8 µg/ml, respectively. There was a significant difference between the groups in terms of the prepartum and postpartum TN-C levels (p < 0.017, Mann–Whitney U [MWU] test). There was also a significant difference in the prepartum TN-C levels between Groups 2 and 3 (p < 0.017, MWU test). Conclusions: The prepartum and postpartum TN-C levels were significantly higher in mild and severe preeclampsia than those in healthy pregnants.


Drug Design Development and Therapy | 2014

The efficacy of ampicillin and Lactobacillus casei rhamnosus in the active management of preterm premature rupture of membranes remote from term.

Salih Burcin Kavak; Ebru Çelik Kavak; Rasit Ilhan; Remzi Atilgan; Ozgur Arat; Ugur Deveci; Ekrem Sapmaz

Background We aimed to investigate the treatment efficacy of ampicillin prophylaxis accompanied by Lactobacillus casei rhamnosus over the latency period following preterm premature rupture of membranes (PPROM). Methods Records of 40 patients who presented with PPROM between 230/7–316/7 weeks were analyzed retrospectively. Patients were divided into two groups: group 1 (n=20), treated with ampicillin; and group 2 (n=20), treated with ampicillin plus L. casei rhamnosus. Clinical and laboratory parameters were compared. Delta (Δ) values of each laboratory parameter were calculated by subtracting the value at delivery from the values at admission to the clinic. Results Gestational weeks at delivery (28.1±0.3 weeks versus 31.5±0.4 weeks), latency periods (12.3±1.5 days versus 41.4±4.4 days), 5-minute APGAR scores (6.8±0.1 versus 7.8±0.1), and birth weights (1,320±98 g versus 1,947±128 g) were significantly higher in group 2. White blood cell (WBC) (12,820±353/mm3 versus 11,107±298/mm3), and neutrophil counts (10.7±0.5×103/L versus 8.2±0.5×103/L) were significantly lower in group 2 at delivery. The ΔWBC (2,295±74/mm3 versus −798±−406/mm3), ΔC-reactive protein (5±0.04 mg/L versus 1.6±0.2 mg/L), and Δneutrophil (3±0.2×103/L versus 0.2±−0.1×103/L) were significantly lower in group 2. Conclusion It seems that addition of L. casei rhamnosus to ampicillin prolongs the latency period in patients with PPROM remote from term.


Global Journal of Health Science | 2014

Evaluation of maternal mortality cases in the province of Elazig, Turkey, 2007-2013: a retrospective study.

Salih Burcin Kavak; Ebru Çelik Kavak; İsmail Demirel; Abdurrahim Turkoglu; Ibrahim Halil Akkus; Rasit Ilhan; Selçuk Kaplan

The aim of this study was to determine the causes and factors influencing maternal mortality. All maternal deaths occurring between January 2007 and November 2013 in the Elazıg Province of Turkey were retrospectively investigated. The maternal age, obstetric history, cause of death, encountered delay model of each case, as well as the overall number of annual live births in the Province were determined. The information of cases was obtained from Directorate of Public Health and hospital records. Families or family doctors were also interviewed to obtain details about the circumstances surrounding each death. There were a total of 64,423 live births in the Province of Elazıg between 2007–2013. The number and ratio of maternal deaths due to direct and indirect causes were 12 and 18.6, respectively. The direct causes of maternal death were hypertensive diseases of pregnancy (n=5, 41.7%), obstetric hemorrhages (n=3, 25%) and pulmonary embolism (n=1, 8.3%). The indirect causes of death were cardiac diseases (n=2, 16.7%) and malignancy (n=1, 8.3%). When classified according to the “Three Delays Model”, 2 cases were in the first delay model and 3 cases in the third delay model; the second delay model led to no maternal deaths. Hypertensive diseases of pregnancy are the leading cause of maternal mortality in our province. The preventable causes of maternal mortality and factors contributing to death must be identified to reduce the incidence.


Drug Design Development and Therapy | 2018

Magnesium: does it reduce ischemia/reperfusion injury in an adnexal torsion rat model?

Ebru Çelik Kavak; Funda Gülcü Bulmuş; Ozgur Bulmus; Salih Burcin Kavak; Nevin Kocaman

Aim The aim of the present study was to assess the protective effects of magnesium sulfate (MgSO4) on ischemia/reperfusion (I/R) induced ovarian damage in a rat ovarian torsion model. Methods Forty-two female Sprague Dawley rats were included in the study. They were divided into six groups as Group 1, sham; Group 2, bilateral ovarian torsion; Group 3, bilateral ovarian torsion–detorsion; Group 4, MgSO4–sham; Group 5, MgSO4–bilateral ovarian torsion; Group 6, bilateral ovarian torsion–MgSO4–detorsion. Both torsion and detorsion periods lasted 3 hours. In Groups 4, 5 and 6, MgSO4 (600 mg/kg) was administered by intraperitoneal route 30 minutes before sham operation, torsion and detorsion, respectively. At the end of the study period, both ovaries were removed. One of the ovaries was used for histopathological analyses and the other for biochemical analyses. Results In the torsion–detorsion group, all the histopathological scores were higher compared to the sham and torsion only group (p<0.05). Administration of MgSO4 only caused significant decrease in the inflammatory cell scores of the torsion–detorsion group (p<0.05). MgSO4, whether given before torsion or before detorsion, suppressed malondialdehyde levels when compared to the untreated groups (p<0.01 and p<0.001, respectively). Glutathione peroxidase activities were significantly higher in the MgSO4 applied torsion and detorsion groups than Groups 2 and 3 (p<0.05, for both). Administration of MgSO4 also caused an increase in glutathione levels in the torsion and detorsion groups compared to the torsion only and detorsion only groups (p<0.05, for both). Also, total oxidant status levels decreased in the MgSO4 applied torsion and detorsion groups compared to the untreated corresponding ones (p<0.01 and p<0.001, respectively). MgSO4 significantly decreased the Oxidative Stress Index levels in the torsion–detorsion group compared to Group 2 (p<0.001). Conclusion Histopathological and biochemical analysis revealed that prophylactic treatment with MgSO4 reduces the changes observed in I/R injury in a rat model.


Journal of Genetic Disorders & Genetic Reports | 2016

Fetuin A Concentration in the Amniotic Fluid of Fetuses with Down Syndrome

Salih Burcin Kavak; Ebru Çelik Kavak; Askin Sen; Rasit Ilhan; Murat Kaya; Ekrem Sapmaz; Ozgur Arat; Sel uk Kaplan; Melike Baspinar

Fetuin A Concentration in the Amniotic Fluid of Fetuses with Down Syndrome Background: Fetuin-A is a plasma protein called Alfa 2- Heremans Schmid glycoprotein. During the fetal life, it is the major component of non-collagenous bone matrix. The aim of this study was to examine the probable variation of Fetuin A which is produced by the fetal liver and trophoblastic tissue and found in abundance in the amniotic fluid Methods: Twenty cases in which amniocentesis were performed were included in the study between December 2012 and December 2013. Amniotic fluid samples were collected from women who underwent amniocentesis in the second trimester of pregnancy. Conventional cytogenetic culture was performed and ten fetuses with Down Syndrome (DS) were identified. They were classified as Group 1 and ten fetuses with normal karyotype were classified as Group 2. Levels of FetuinA in the amniotic fluid were measured in each group. Results: Age, gender, gestational age, obstetrics history and body mass index of the cases in Group 1 and Group 2 were similar. Mean amnion fluid Fetuin-A levels in Group 1 was 3.5 ± 0.4 ng/mL and these values were detected to be 4.7 ± 0.7 ng/mL in Group 2. There was statistically significant difference between the mean amniotic fluid Fetuin-A levels of two groups. (P=0.001 from the Mann-Whitney U test). Conclusion: In the present study, amnion fluid Fetuin-A levels were found to be significantly lower in the presence of DS. Decreased Fetuin-A levels may be effective on antenatal and postnatal developments of fetuses with DS. By the clarification of its importance treatment modalities may be developed.


Journal of Obstetrics and Gynaecology Research | 2015

Evaluation of vitamin C and vitamin E for prevention of postoperative adhesion: A rat uterine horn model study

Remzi Atilgan; Tuncay Kuloglu; Zehra Sema Ozkan; Salih Burcin Kavak; Banu Kumbak; Derya Deveci; Mehmet Simsek; Melike Baspinar; Ekrem Sapmaz

To investigate the effectiveness of intraperitoneal vitamin C (VC) and vitamin E (VE) in the prevention of postoperative adhesion formation in a rat uterine horn model.

Collaboration


Dive into the Salih Burcin Kavak's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge